Literature DB >> 11862658

Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard.

Henraya F Davis1, Richard L Skolasky, Ola A Selnes, David M Burgess, Justin C McArthur.   

Abstract

The HIV dementia scale (HDS) previously has been shown to be sensitive in identifying persons with HIV-associated dementia (HAD). We aimed to develop a simpler version of the HDS--the Modified HDS (M-HDS)--which would be appropriate for use by nonneurologists. We sought to determine whether the M-HDS and the widely used Grooved Pegboard (GP) were comparable in identifying and staging the severity of dementia in HIV-seropositive persons. Data from 455 HIV-seropositive persons were analyzed, and patients were separated into 2 groups: demented (n = 144) and nondemented (n = 311), where the diagnosis was established by a single neurologist. Of the 144 with HAD, 13 had severe dementia, 55 had moderate dementia, 51 had mild dementia, and 25 had minor cognitive/motor disorder. We assessed the relationship between dementia severity and score on the M-HDS and GP (nondominant hand). Results showed both the M-HDS (z = -4.32; P < .05) and the GP nondominant (z = -4.08; P < .05) differentiated demented from nondemented persons. Furthermore, the M-HDS (z = -2.95; P < .05) and GP nondominant (z = -2.68; P < .05) discriminated equally well the stages of dementia severity. A cutoff score of 7.5 on the M-HDS maximized its sensitivity (70%) and specificity (71%). The M-HDS and the GP (nondominant) were found to be equally sensitive and specific in categorizing and staging HAD. However, the M-HDS requires no equipment and is simpler to administer; so it may be more useful for screening by nonneurologists.

Entities:  

Mesh:

Year:  2002        PMID: 11862658

Source DB:  PubMed          Journal:  AIDS Read        ISSN: 1053-0894


  15 in total

1.  Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.

Authors:  Karl Goodkin; David J Hardy; Dinesh Singh; Enrique Lopez
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

2.  Limitations of the International HIV Dementia Scale in the current era.

Authors:  Benedetta Milanini; Robert Paul; Emmanuel Bahemana; Yakubu Adamu; Francis Kiweewa; Rither Langat; John Owuoth; Elaine Allen; Christina Polyak; Julie Ake; Victor Valcour
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

Review 3.  Screening for cognitive impairment in human immunodeficiency virus.

Authors:  Victor Valcour; Robert Paul; Stephanie Chiao; Lauren A Wendelken; Bruce Miller
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

4.  Evaluating cognitive impairment in the clinical setting: practical screening and assessment tools.

Authors:  Victor G Valcour
Journal:  Top Antivir Med       Date:  2011-12

5.  Distal sensory polyneuropathy is associated with neuropsychological test performance among persons with HIV.

Authors:  Robert P Fellows; Desiree A Byrd; Kathryn Elliott; Jessica Robinson-Papp; Monica Rivera Mindt; Susan Morgello
Journal:  J Int Neuropsychol Soc       Date:  2012-06-12       Impact factor: 2.892

6.  HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.

Authors:  N S Ku; Y Lee; J Y Ahn; J E Song; M H Kim; S B Kim; S J Jeong; K-W Hong; E Kim; S H Han; J Y Song; H J Cheong; Y G Song; W J Kim; J M Kim; D M Smith; J Y Choi
Journal:  HIV Med       Date:  2014-02-24       Impact factor: 3.180

7.  The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons.

Authors:  Edgar Turner Overton; Tej D Azad; Neva Parker; Debra Demarco Shaw; Judy Frain; Teresa Spitz; Elizabeth Westerhaus; Robert Paul; David B Clifford; Beau M Ances
Journal:  J Neurovirol       Date:  2013-01-24       Impact factor: 2.643

8.  An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults.

Authors:  Andrew J Levine; Charles H Hinkin; Kazuhiro Ando; Gianni Santangelo; Mariana Martinez; Miguel Valdes-Sueiras; Ernestina H Saxton; Glen Mathisen; Deborah L Commins; Ardis Moe; Charles Farthing; Elyse J Singer
Journal:  J Clin Exp Neuropsychol       Date:  2008-02-08       Impact factor: 2.475

9.  Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort.

Authors:  Maiko Sakamoto; Thomas D Marcotte; Anya Umlauf; Donald Franklin; Robert K Heaton; Ronald J Ellis; Scott Letendre; Terry Alexander; J A McCutchan; Erin E Morgan; Steven P Woods; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David Simpson; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2013-01-01       Impact factor: 3.731

Review 10.  2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.

Authors:  R Douglas Bruce; Jessica Merlin; Paula J Lum; Ebtesam Ahmed; Carla Alexander; Amanda H Corbett; Kathleen Foley; Kate Leonard; Glenn Jordan Treisman; Peter Selwyn
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.